Douglas Jamison

Douglas Jamison

Chairman and CEO in Harris & Harris

From 2005 to 2008, Mr. Jamison served as President and Chief Operating Officer. From 2002 to 2004, he served as Vice President of Harris & Harris Group. Mr. Jamison also served as Chief Financial Officer from 2005 to 2007.
Portfolio responsibilities: Ancora Pharmaceuticals, Mersana Therapeutics, Metabolon, Nextreme Thermal Solutions, Solazyme and Starfire Systems.

Prior to joining Harris & Harris Group, he was a Sr. Technology Manager in the University of Utah Technology Transfer Office. He is a graduate of Dartmouth College (B.A., 1992) and the University of Utah (M.S., 1999). He is a Director of Harris & Harris Enterprises, Inc., a wholly owned subsidiary of Harris & Harris Group, Inc. He is a Director of two private Harris & Harris Group portfolio companies, NanoOpto Corporation and  Nextreme Thermal Solutions,  and a member of the Scientific Advisory Board of Chlorogen, Inc. He is Co-Editor-in-Chief, Journal of Nanotechnology Law & Business; Co-Chair of the Advisory Board, Converging Technology Bar Association; a member of the Advisory Board of MIT’s Deshpande Center IdeaStream and a member of the Advisory Board, Massachusetts Technology Collaborative Nanotechnology Venture Forum.  His professional societies include the Association of University Technology Managers, for which he serves on its Survey Statistics and Metrics Committee.

Contenido relacionado

by experts
by thought